IRS Issues Final Rule Implementing Medical Device Excise Tax
The Internal Revenue Service released a
implementing a Patient Protection and Affordable Care Act provision that imposes on certain medical devices made after 2012 an excise tax equal to 2.3% of their sales price. In submitted on the proposed rule AHRMM, the American Hospital Association and others urged the IRS to explicitly prohibit device companies from passing the tax on to customers, and to clarify that hospitals and other healthcare providers who package and sterilize devices for use in surgery kits should not be treated as device manufacturers or importers under the rule. The final rule does not address AHRMM’s recommendation that manufacturers certify that the tax has not been passed on to customers, but provides that current rules apply in determining the sales price of items. Also, of importance, the final rule states that a kit produced by a hospital or medical institution for its own use would not be a taxable medical device.Related Resources
White Papers
A well-conceived strategic sourcing program starts with an analysis of the total spend or operating expenses of the organization utilizing an
White Papers
Purchasing in healthcare is largely based on a hierarchical management style.
White Papers
The purpose of this paper is to share lessons learned and successes in contract management.
White Papers
The initial purpose for developing a socially responsible, closed loop supply chain was to enhance our environmentally sustainable practices by p
White Papers
This is an on-going operational excellence initiative and our results have certainly validated our approach and produced an immediate beneficial